OPRK1 and Alzheimer disease: In contrast to MOR, KOR expression was found to be significantly lower in AD patients, and PUVA therapy (0.6 mg/kg 8-methoxypsoralen p.o., 2–6 J/cm2 UVA) did not influence its staining intensity [103].